about
The role of the substantia nigra pars compacta in regulating sleep patterns in ratsGenotyping Parkinson disease-associated mitochondrial polymorphismProteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactionsSerum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expressionThe antioxidative effect of electro-acupuncture in a mouse model of Parkinson's diseaseS-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegenerationIdentification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's diseaseA specific fluorescent probe reveals compromised activity of methionine sulfoxide reductases in Parkinson's disease.A behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling.Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic.Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.Granular assembly of alpha-synuclein leading to the accelerated amyloid fibril formation with shear stress.Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease.Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's diseaseFatty acids in energy metabolism of the central nervous systemDifferent susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's DiseaseAn in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats.Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stressalpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.Zhichan decoction induces differentiation of dopaminergic neurons in Parkinson's disease rats after neural stem cell transplantation.Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism.Evidence of D-phenylglycine as delivering tool for improving L-dopa absorptionA single point mutation in ecdysone receptor leads to increased ligand specificity: implications for gene switch applicationsRepairing the brain in Parkinson's disease: where next?Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.Drosophila models of neurodegenerative diseases.Antioxidants as treatment for neurodegenerative disorders.Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.1-Methyl-4-phenylpyridinium stereotactic infusion completely and specifically ablated the nigrostriatal dopaminergic pathway in rhesus macaqueNeurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review.Targeting Dopamine in Acute Traumatic Brain InjuryNMR Metabolomics Analysis of Parkinson's DiseaseParkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice.Mitochondrial quality control and dynamics in Parkinson's diseaseCombined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.Autophagic stress in neuronal injury and disease.
P2860
Q21562323-842A214D-187B-4590-8768-F71C683D599CQ23924039-25A2CC2A-BA1A-4A1B-8383-0C223D1FF9DBQ24311624-D3FCC1FF-F0A9-41E4-841B-D4EED304894FQ25257546-C83B096B-8DEE-4122-86CC-406C0C1A5235Q27342258-00641025-5166-4B61-BE65-02414C8835E1Q27694603-A703038E-6D69-40EA-8B4C-3FB41DEA7E4BQ28539943-AA424B7C-F62D-405B-9993-5D11C10B65DBQ30401465-D1D2BBD4-FB7D-4705-BD00-048BC029B8B6Q30474975-D36DEEF0-8982-4E40-9D5B-11802AFE994BQ30512976-FF87903F-C064-4E45-8030-A4C7FF75D124Q30525658-E8C05CF1-8305-4242-8B42-65D159E86452Q31132651-D3FE4295-50A9-4494-B227-683AA5A9B2A3Q33399100-79F6454B-D45C-437E-9823-E7D04BA261B3Q33517934-976F77F8-3BEB-4968-99B7-D402E39F1BDAQ33606408-4749BAAF-CD08-411B-9D1C-04DCD64337BFQ33634475-D7D2141F-299E-4B09-A934-5B232B1B2317Q33646741-3E439E73-B54C-4F1A-AE83-8F8D45042D10Q33749270-DF6588D9-921C-4424-BEAD-B1CACFDDFB98Q33876743-6F2FDE63-67B7-4F95-8525-9C89399D5F38Q33991775-16C21DA7-7DF6-4454-A2F5-D157DE40FF00Q34076094-725881D9-B0EC-4472-895E-63DBB2C59ACEQ34091754-BCA48791-4850-4781-A2CF-9A9AE18974E0Q34095964-FF974165-38B6-41E4-8035-7F634103D3D1Q34134659-1564E2E3-2E0B-4FBB-B329-93875B571061Q34137524-9F537493-AA0C-4929-BC21-E641AEBD5E49Q34379052-304DAB6C-45EB-4D4A-9752-E3FC507AA6A0Q34580635-FDACC6D2-2447-40D6-ADF3-8F59BB3860F7Q34584417-45E08D98-952B-4B0F-826B-50039A6124D6Q34610331-36EEB17C-F45B-4818-B0AD-B2AA00B0320EQ34974866-A5A4559E-C5E9-4D25-B817-3A3E9A8C9FBBQ35053448-20FBA421-5DC7-4865-B109-CB8030D5E78DQ35641515-B9ADECC8-4E31-4CD6-B6E8-AFD2CA8C902AQ35710568-96C24808-1C42-4B2F-B512-41C85E7C0623Q35720254-984BCA80-EA82-4F73-BC12-D783FF457A3FQ35734379-385ECF95-FB0E-4BB4-9081-F88D50D83029Q35782960-F287C213-7DF1-465C-B33A-E67F1E4A9CC4Q35799128-7F33457A-8CF2-407B-A648-3373E0EFE3B1Q35822548-9BEB7D20-E5A1-4369-9C4F-7A361DC07D71Q35827966-17E4D86F-49FA-4C47-8FA8-3BDE60CD6380Q35828319-DF46B385-AC84-4304-B2CE-6C5516C5ECBD
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Experimental models of Parkinson's disease.
@ast
Experimental models of Parkinson's disease.
@en
Experimental models of Parkinson's disease.
@nl
type
label
Experimental models of Parkinson's disease.
@ast
Experimental models of Parkinson's disease.
@en
Experimental models of Parkinson's disease.
@nl
prefLabel
Experimental models of Parkinson's disease.
@ast
Experimental models of Parkinson's disease.
@en
Experimental models of Parkinson's disease.
@nl
P356
P1476
Experimental models of Parkinson's disease.
@en
P2093
P2888
P304
P356
10.1038/35072550
P407
P577
2001-05-01T00:00:00Z
P6179
1050001570